Your browser doesn't support javascript.
loading
Efficacy of Osimertinib Plus Bevacizumab vs Osimertinib in Patients With EGFR T790M-Mutated Non-Small Cell Lung Cancer Previously Treated With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor: West Japan Oncology Group 8715L Phase 2 Randomized Clinical Trial.
Akamatsu, Hiroaki; Toi, Yukihiro; Hayashi, Hidetoshi; Fujimoto, Daichi; Tachihara, Motoko; Furuya, Naoki; Otani, Sakiko; Shimizu, Junichi; Katakami, Nobuyuki; Azuma, Koichi; Miura, Naoko; Nishino, Kazumi; Hara, Satoshi; Teraoka, Shunsuke; Morita, Satoshi; Nakagawa, Kazuhiko; Yamamoto, Nobuyuki.
Afiliación
  • Akamatsu H; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
  • Toi Y; Department of Pulmonary Medicine, Sendai Kousei Hospital, Miyagi, Japan.
  • Hayashi H; Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka, Japan.
  • Fujimoto D; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Hyogo, Japan.
  • Tachihara M; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Hyogo, Japan.
  • Furuya N; Division of Respiratory Medicine, Department of Internal Medicine, St Marianna University School of Medicine, Kanagawa, Japan.
  • Otani S; Department of Respiratory Medicine, Kitasato University School of Medicine, Kanagawa, Japan.
  • Shimizu J; Department of Thoracic Oncology, Aichi Cancer Center Hospital, Aichi, Japan.
  • Katakami N; Department of Medical Oncology, Department of Pulmonary Medicine, Chemotherapy Center and Division of Clinical Research, Takarazuka City Hospital, Hyogo, Japan.
  • Azuma K; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Fukuoka, Japan.
  • Miura N; Department of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Nishino K; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Hara S; Department of Respiratory Medicine, Itami City Hospital, Hyogo, Japan.
  • Teraoka S; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
  • Morita S; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Nakagawa K; Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka, Japan.
  • Yamamoto N; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
JAMA Oncol ; 7(3): 386-394, 2021 Mar 01.
Article en En | MEDLINE | ID: mdl-33410885
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de la Angiogénesis / Bevacizumab / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: JAMA Oncol Año: 2021 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de la Angiogénesis / Bevacizumab / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: JAMA Oncol Año: 2021 Tipo del documento: Article País de afiliación: Japón